PRDS

Pardes Biosciences, Inc. Common Stock

Delisted

PRDS was delisted on the 30th of August, 2023.

57 hedge funds and large institutions have $282M invested in Pardes Biosciences, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 13 increasing their positions, 13 reducing their positions, and 5 closing their positions.

Holders
57
Holders Change
+16
Holders Change %
+39.02%
% of All Funds
0.9%
Holding in Top 10
4
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-42.86%
% of All Funds
0.06%
New
21
Increased
13
Reduced
13
Closed
5
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
Royal Bank of Canada
51
Royal Bank of Canada
Ontario, Canada
$13K +$13K +1,823 New
TRCT
52
Tower Research Capital (TRC)
New York
$10K +$7.98K +1,112 +396%
APA
53
American Portfolios Advisors
New York
$7.22K
National Bank of Canada
54
National Bank of Canada
Quebec, Canada
$7K
OCM
55
Ovata Capital Management
Hong Kong
$4K +$4K +500 New
Wells Fargo
56
Wells Fargo
California
$2K -$117K -18,944 -98%
UBS Group
57
UBS Group
Switzerland
$1K
FM
58
Frazier Management
Washington
-$40.2M -2,457,507 Closed
JCM
59
JS Capital Management
New York
-$16.4M -1,000,000 Closed
Citadel Advisors
60
Citadel Advisors
Florida
-$4.91M -300,000 Closed
HF
61
HRT Financial
New York
-$1.15M -69,962 Closed
PHK
62
Point72 Hong Kong
Hong Kong
-$1K -34 Closed